{
    "pmcid": "8967028",
    "summary": "The paper \"Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody\" presents a comprehensive study on the optimization of the VHH-72 single-domain antibody to enhance its binding affinity to the SARS-CoV-2 spike protein while retaining its affinity for the SARS-CoV-1 spike protein. The study employs a structure-based approach using the ADAPT platform, which integrates computational predictions with experimental validation to achieve dual-affinity optimization.\n\n### Key Insights on \"Rosetta\" in Designing SARS-CoV-2 Nanobody Binders:\n\n1. **Role of Rosetta in Computational Design**:\n   - Rosetta is one of the three computational protocols used in the ADAPT platform for evaluating the energies of single-point mutations. It is employed alongside SIE-SCWRL and FoldX to build structures and score the binding affinities of VHH-72 mutants.\n   - The consensus approach combines results from Rosetta, SIE, and FoldX to predict the most promising mutations for experimental testing. This method helps in identifying mutations that could potentially improve binding affinity to the SARS-CoV-2 spike protein.\n\n2. **Mutation Scanning and Scoring**:\n   - Rosetta-Interface is specifically used to score the binding affinity of VHH-72 mutants. The scoring is based on the average Z-score and rank score over the energy functions from the three protocols.\n   - The consensus scoring approach, which includes Rosetta, helps in filtering out mutations that are predicted to destabilize the VHH structure or negatively impact binding affinity.\n\n3. **Structural Insights and Predictions**:\n   - Rosetta contributes to the structural modeling and prediction of how mutations might affect the binding interface between VHH-72 and the SARS-CoV-2 spike protein.\n   - The computational predictions, including those from Rosetta, guide the selection of mutations that introduce new interactions or enhance existing ones at the binding interface, thereby improving binding affinity.\n\n4. **False-Positive Predictions**:\n   - The study acknowledges the occurrence of false-positive predictions, where some mutations predicted to improve binding did not perform as expected experimentally. Rosetta, as part of the consensus approach, plays a role in these predictions.\n   - The analysis of false positives highlights the challenges in accurately predicting the balance between new non-polar contacts and steric strain, as well as the balance between electrostatic interactions and solvation effects.\n\n5. **Impact on Binding Affinity and Neutralization**:\n   - The use of Rosetta in the computational design process contributes to the identification of mutations that significantly improve the binding affinity of VHH-72 to the SARS-CoV-2 spike protein.\n   - The optimized VHH-72 mutants, guided by Rosetta and other computational tools, demonstrate enhanced virus neutralization capabilities in vitro and in vivo, underscoring the effectiveness of the structure-based design approach.\n\nIn summary, Rosetta plays a crucial role in the computational design and optimization of VHH-72 nanobody binders for SARS-CoV-2. It is part of a consensus approach that integrates multiple computational tools to predict and evaluate mutations, ultimately guiding the development of nanobodies with improved binding affinity and neutralization efficacy against SARS-CoV-2.",
    "title": "Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody"
}